Myomo Inc. (MYO) is a publicly traded Healthcare sector company. As of May 21, 2026, MYO trades at $0.91 with a market cap of $32.42M and a P/E ratio of -2.52. MYO moved +4.76% today. Year to date, MYO is -15.30%; over the trailing twelve months it is -72.77%. Its 52-week range spans $0.61 to $7.17. Analyst consensus is strong buy with an average price target of $4.32. Rallies surfaces MYO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Myomo Posts Record $11.4M Revenue, Net Loss Widens to $3.8M: Myomo reported a Q4 2025 net loss of $3.8 million, compared with a $0.3 million loss a year earlier, with adjusted EBITDA turning negative. Revenue hit a record $11.4 million, driven by 46% quarterly and 48% annual international gains exceeding $2 million, and management projects 2026 revenue of $43–$46 million.
| Metric | Value |
|---|---|
| Price | $0.91 |
| Market Cap | $32.42M |
| P/E Ratio | -2.52 |
| EPS | $-0.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.17 |
| 52-Week Low | $0.61 |
| Volume | 1.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $41.21M |
| Net Income | $-15.12M |
| Gross Margin | 65.96% |
5 analysts cover MYO: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.32.